NEW YORK (GenomeWeb News) – Atossa Genetics today announced it has entered into a contract with preferred provider organization FedMed, giving its members access to Atossa's breast health tests.

FedMed has more than 550,000 providers in its network, including 4,000 hospitals, and more than 60,000 ancillary facilities. It serves more than 40 million Americans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.